A Multiple Increasing Dose Safety and Tolerability Study After Inhalation Administration of BIIX 1 XX in Healthy Male Volunteers

NCT02198313 ↗

Phase 1 Terminated 8 enrolled Boehringer Ingelheim

RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of the present study is to obtain information about the safety and tolerability of multiple increasing doses of BIIX 1 XX and to obtain preliminary pharmacokinetic data

Timeline

Start: 1999-04
Primary completion: 1999-04
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	BIIX 1 XX	Unknown	100 ug	Inhaled
Subject	BIIX 1 XX	Unknown	200 ug	Inhaled
Subject	BIIX 1 XX	Unknown	400 ug	Inhaled

Indications

No indication recorded.